References
- Arslan, S., et al., 2017. Long non-coding RNAs in the atherosclerotic plaque. Atherosclerosis, 266, 176–181.
- Ceviker, K., Bagcı, O., and Yazkan, R., 2016. Unknown Aspects of Well-known Cardiovascular Diseases: Identification of Novel miRNA Genes. Journal of clinical and analytical medicine, 7 (4), 575–580.
- Chistiakov, D.A., et al., 2014. Human MiR-221/222 in physiological and atherosclerotic vascular remodeling. BioMed research international, 1–18.
- Davis, B.N., et al., 2009. Induction of MicroRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. Journal of biological chemistry, 284, 3728–3738.
- Derksen, W.J.M., et al., 2011. Age and coumarin-type anticoagulation are associated with the occurrence of intraplaque hemorrhage, while statins are associated less with intraplaque hemorrhage: a large histopathological study in carotid and femoral plaques. Atherosclerosis, 214 (1), 139–143.
- Di Leva, G., et al., 2010. MicroRNA cluster 221–222 and estrogen receptor alpha interactions in breast cancer. Journal of the national cancer institute, 102 (10), 706–721.
- Graupera, M., et al., 2008. Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration. Nature, 453 (7195), 662–666.
- Head, S.J., et al., 2017. Current practice of state-of-the-art surgical coronary revascularization. Circulation, 136, 1331–1345.
- Izawa, H. and Amano, T., 2015. Plasma microRNA-100 as a biomarker of coronary plaque vulnerability – a new generation of biomarker for developing acute coronary syndrome. Circulation journal, 79 (2), 303–304.
- Jia, Q.W., et al., 2017. Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China. Cellular physiology and biochemistry, 42 (2), 808–823.
- Liu, X., et al., 2012. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. Journal of molecular and cellular cardiology, 52, 245–255.
- Liu, X.D., et al., 2012. Effects of dietary L-arginine or N-carbamylglutamate supplementation during late gestation of sows on the miR-15b/16, miR-221/222, VEGFA and eNOS expression in umbilical vein. Amino acids, 42, 2111–2119.
- Madrigal-Matute, J., et al., 2013. MicroRNAs and atherosclerosis. Current atherosclerosis reports, 15, 322
- Marcelo, K., et al., 2013. Hemogenic endothelial cell specification requires c-Kit, notch signaling, and p27-mediated cell-cycle control. Developmental cell, 27 (5), 504–515.
- Poliseno, L., et al., 2006. MicroRNAs modulate the angiogenic properties of HUVECs. Blood, 108, 3068–3071.
- Quintavalle, M., Condorelli, G., and Elia, L., 2011. Arterial remodeling and atherosclerosis: miRNA involvement. Vascular pharmacology, 55, 106–110.
- Raitoharju, E., et al., 2011. miR-21, miR-210, miR-34a and miR-146a/b are Up-regulated in human atherosclerotic plaques in the Tampere vascular study. Atherosclerosis, 219 (1), 211–217.
- Reid, G., Kirschner, M.B., and Van Zandwijk, N., 2011. Circulating MicroRNAs: association with disease and potential use as biomarkers. Critical reviews in oncology/hematology, 80, 193–208.
- Tijsen, A.J., Pinto, Y.M., and Creemers, E.E., 2012. Circulating MicroRNAs as diagnostic biomarkers for cardiovascular diseases. American journal of physiology-heart and circulatory physiology, 303, 1085–1095.
- Tsai, P.C., et al., 2013. Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease. Journal of vascular research, 50 (4), 346–354.
- Vanhaesebroeck, B., et al., 2010. The emerging mechanisms of isoform-specific PI3K signaling. Nature reviews molecular cell biology, 11 (5), 329–341.
- Volinia, S., et al., 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the national academy of sciences of the United States of America, 103, 2257–2261.
- Wei, Y., Schober, A., and Weber, C., 2012. Pathogenic arterial remodeling: the good and bad of microRNAs. American journal of physiology-heart and circulatory physiology, 304, 1050–1059.
- Xue, Y., et al., 2015. MicroRNA-19b/221/222 induces endothelial cell dysfunction via suppression of PGC-1α in the progression of atherosclerosis. Atherosclerosis, 241 (2), 671–681.
- Zengin, H., 2011. Ateroskleroz Patogenezi. Journal of experimental and clinical medicine, 29, 101–106.